Related Experiment Video

Updated: Jun 19, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer

Eric R Fearon1

  • 1Division of Molecular Medicine & Genetics, Departments of Internal Medicine, Human Genetics and Pathology, and The Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109-22200, USA. fearon@umich.edu

Cancer Cell
|November 3, 2009
PubMed

Insights

Genetic alterations stabilize beta-catenin, driving cancer. Targeting tankyrase

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Genetic alterations leading to constitutive beta-catenin stabilization are common in various cancers.
  • Aberrant transcription of beta-catenin/TCF-regulated genes contributes to tumorigenesis.
  • The Wnt/beta-catenin pathway is a critical regulator of cell growth and differentiation, often dysregulated in cancer.

Purpose of the Study:

  • To elucidate the role of tankyrase in regulating the Wnt/beta-catenin pathway.
  • To explore the therapeutic potential of targeting tankyrase's enzymatic activity in cancer treatment.

Main Methods:

  • Analysis of genetic alterations affecting beta-catenin stability.
  • Investigation of tankyrase's function in Wnt/beta-catenin signaling.
  • Evaluation of tankyrase-targeting compounds, specifically those inhibiting poly-ADP-ribosylation (PARsylation).

Main Results:

  • Tankyrase plays a key role in modulating the Wnt/beta-catenin pathway.
  • Inhibition of tankyrase's poly-ADP-ribosylation (PARsylation) activity impacts pathway regulation.
  • Compounds targeting tankyrase PARsylation demonstrate potential for cancer therapy.

Conclusions:

  • Tankyrase is a crucial regulator of the Wnt/beta-catenin pathway.
  • Targeting tankyrase's PARsylation activity represents a promising therapeutic strategy for cancers with aberrant beta-catenin signaling.
  • Further research into tankyrase inhibitors could lead to novel cancer treatments.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...